AMBER MATTHYSSE: Open Payments
NPI 1558455311 · WYOMING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,455 in 76 payments from 20 companies in 2025. Trend: 2023 $749 · 2024 $2,690 · 2025 $1,455
Food & beverage: $1,445Education: $10
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $286 |
| Organon LLC | 19 | $226 |
| ABBVIE INC. | 9 | $190 |
| Novartis Pharmaceuticals Corporation | 5 | $113 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $74 |
| Amgen Inc. | 3 | $70 |
| Janssen Biotech, Inc. | 3 | $60 |
| UCB, Inc. | 3 | $59 |
| Arcutis Biotherapeutics, Inc. | 2 | $47 |
| Incyte Corporation | 2 | $46 |
Products named: DUPIXENT, VTAMA, SKYRIZI, COSENTYX, OTEZLA, RINVOQ, TREMFYA, Bimzelx.
Industry payments across MI — which companies pay providers there.
